“Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.”, PLoS One, vol. 3, no. 4, p. e2043, 2008.
, “Baseline Nutritional Characteristics of the Age-Related Eye Disease Study 2 (AREDS2) Cohort”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
, “Baseline nutritional status of AREDS participants, Poster presentation by AREDS participants”, Experimental Biology, 1999.
, “Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss”, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
, “Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10”, Ophthalmology, vol. 118, pp. 345-352, 2011.
, “Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.”, Ophthalmology, vol. 118, no. 2, pp. 345-52, 2011.
, , “B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.”, Clin Vaccine Immunol, vol. 24, no. 5, 2017.
, “Beneficial effect on non-inherited maternal antigens on graft survival in pediatric renal transplantation,”, J Am Soc Nephrol, vol. 7, p. 1917, 1996.
, “Best Method for Right Atrial Volume Assessment by Two-Dimensional Echocardiography: Validation with Magnetic Resonance Imaging”, Echocardiography, vol. 32, pp. 734-739, 2015.
, “Best method for right atrial volume assessment by two-dimensional echocardiography: validation with magnetic resonance imaging.”, Echocardiography, vol. 32, no. 5, pp. 734-9, 2015.
, “Best Single Time Point Correlations with AUC for Cyclosporine and Tacrolimus in HIV-Infected Kidney and Liver Transplant Recipients”, Transplantation, vol. 97, pp. 702-707, 2014.
, “Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients.”, Transplantation, vol. 97, no. 6, pp. 702-7, 2014.
, “The best single time point measurement correlations with AUC for cyclosporine and tacrolimus in HIV-1 infected liver and kidney transplant recipients (poster session)”, in World Congress of Nephrology, Vancouver, Canada, 2011.
, “Biofeedback/relaxation training and exercise intervention for fibromyalgia: A prospective trial”, Arthritis Care and Research, vol. 11, pp. 196-209, 1998.
, “Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial.”, Arthritis Care Res, vol. 11, no. 3, pp. 196-209, 1998.
, “Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome.”, J Clin Oncol, vol. 39, no. 30, pp. 3328-3339, 2021.
, “Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans.”, J Infect Dis, vol. 219, no. 2, pp. 284-294, 2019.
, “Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores.”, Genetics, vol. 206, no. 1, pp. 119-133, 2017.
, “BK and JC Polyomavirus (PyV) in HIV-1 Infected Kidney Transplant Recipients (KTR)”, in Interscience Conference on Antimicrobial Agents and Chemotherapy - ICAAC 2013, Denver, CO, 2013.
, “BK virus is not a significant cause of graft loss in HIV+ kidney recipients (oral presentation)”, presented at the 2011, Philadelphia, PA, 2011.
, “BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry.”, Clin J Am Soc Nephrol, vol. 2, no. 5, pp. 1037-42, 2007.
, “Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions”, Biol Blood Marrow Transplant, vol. 13, pp. 257-262, 2007.
, “Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.”, Biol Blood Marrow Transplant, vol. 13, no. 3, pp. 257-62; discussion 255-6, 2007.
, “Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.”, Biol Blood Marrow Transplant, vol. 24, no. 6, pp. 1274-1280, 2018.
,